Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab

por Minden, Kirsten, Karunaratne, Mahinda, Kupper, Hartmut, Kalabic, Jasmina
Publicado 2014

Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis

por Rudwaleit, Martin, Claudepierre, Pascal, Kron, Martina, Kary, Sonja, Wong, Robert, Kupper, Hartmut
Publicado 2010

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy

por Rudwaleit, Martin, Van den Bosch, Filip, Kron, Martina, Kary, Sonja, Kupper, Hartmut
Publicado 2010

Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years

por Kingsbury, Daniel J., Bader-Meunier, Brigitte, Patel, Gina, Arora, Vipin, Kalabic, Jasmina, Kupper, Hartmut
Publicado 2014

Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis

por Keystone, Edward C, Breedveld, Ferdinand C, Kupper, Hartmut, Li, Yihan, Florentinus, Stefan, Sainsbury, Iain
Publicado 2018

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoi...

por Kavanaugh, Arthur, Fleischmann, Roy M, Emery, Paul, Kupper, Hartmut, Redden, Laura, Guerette, Benoit, Santra, Sourav, Smolen, Josef S
Publicado 2013

Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study

por Burmester, Gerd R, Matucci-Cerinic, Marco, Mariette, Xavier, Navarro-Blasco, Francisco, Kary, Sonja, Unnebrink, Kristina, Kupper, Hartmut
Publicado 2014

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

por Burmester, Gerd-Rűdiger, Kivitz, Alan J, Kupper, Hartmut, Arulmani, Udayasankar, Florentinus, Stefan, Goss, Sandra L, Rathmann, Suchitrita S, Fleischmann, Roy M
Publicado 2015

Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate

por Kaeley, Gurjit S., Nishio, Midori J., Goyal, Janak R., MacCarter, Daryl K., Wells, Alvin F., Chen, Su, Kupper, Hartmut, Kalabic, Jasmina
Publicado 2016

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis

por van der Heijde, Désirée M, Revicki, Dennis A, Gooch, Katherine L, Wong, Robert L, Kupper, Hartmut, Harnam, Neesha, Thompson, Chris, Sieper, Joachim
Publicado 2009

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

por van der Heijde, Désirée, Salonen, David, Weissman, Barbara N, Landewé, Robert, Maksymowych, Walter P, Kupper, Hartmut, Ballal, Shaila, Gibson, Eric, Wong, Robert
Publicado 2009

Recovery of clinical but not radiographic outcomes by the delayed addition of adalimumab to methotrexate-treated Japanese patients with early rheumatoid arthritis: 52-week results...

por Yamanaka, Hisashi, Ishiguro, Naoki, Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Mukai, Masaya, Matsubara, Tsukasa, Uchida, Shoji, Akama, Hideto, Kupper, Hartmut, Arora, Vipin, Tanaka, Yoshiya
Publicado 2014

Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study

por Takeuchi, Tsutomu, Yamanaka, Hisashi, Ishiguro, Naoki, Miyasaka, Nobuyuki, Mukai, Masaya, Matsubara, Tsukasa, Uchida, Shoji, Akama, Hideto, Kupper, Hartmut, Arora, Vipin, Tanaka, Yoshiya
Publicado 2014

Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid art...

por Kavanaugh, Arthur, van Vollenhoven, Ronald F, Fleischmann, Roy, Emery, Paul, Sainsbury, Iain, Florentinus, Stefan, Chen, Su, Guérette, Benoît, Kupper, Hartmut, Smolen, Josef S
Publicado 2018

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-i...

por van der Bijl, Arie E., Breedveld, Ferdinand C., Antoni, Christian E., Kalden, Joachim R., Kary, Sonja, Burmester, Gerd R., Beckmann, Christina, Unnebrink, Kristina, Kupper, Hartmut
Publicado 2008

Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone

por Keystone, Edward C, Breedveld, Ferdinand C, van der Heijde, Désirée, van Vollenhoven, Ronald F, Emery, Paul, Smolen, Josef S, Sainsbury, Iain, Florentinus, Stefan, Kupper, Hartmut, Chen, Kun, Kavanaugh, Arthur
Publicado 2017

Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab

por van der Heijde, Désirée, Breban, Maxime, Halter, Dale, DiVittorio, Gino, Bratt, Johan, Cantini, Fabrizio, Kary, Sonja, Pangan, Aileen L., Kupper, Hartmut, Rathmann, Suchitrita S., Sieper, Joachim, Mease, Phillip J.
Publicado 2015

Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab

por Burmester, Gerd R, Kaeley, Gurjit S, Kavanaugh, Arthur F, Gabay, Cem, MacCarter, Daryl K, Nash, Peter, Takeuchi, Tsutomu, Goss, Sandra L, Rodila, Ramona, Chen, Kun, Kupper, Hartmut, Kalabic, Jasmina
Publicado 2017

Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan

por Imagawa, Tomoyuki, Takei, Syuji, Umebayashi, Hiroaki, Yamaguchi, Kenichi, Itoh, Yasuhiko, Kawai, Toshinao, Iwata, Naomi, Murata, Takuji, Okafuji, Ikuo, Miyoshi, Mari, Onoe, Yasuhiro, Kawano, Yoshifumi, Kinjo, Noriko, Mori, Masaaki, Mozaffarian, Neelufar, Kupper, Hartmut, Santra, Sourav, Patel, Gina, Kawai, Shinichi, Yokota, Shumpei
Publicado 2012

Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven‐Year Interim Results

por Brunner, Hermine I., Nanda, Kabita, Toth, Mary, Foeldvari, Ivan, Bohnsack, John, Milojevic, Diana, Rabinovich, C. Egla, Kingsbury, Daniel J., Marzan, Katherine, Chalom, Elizabeth, Horneff, Gerd, Kuester, Rolf‐Michael, Dare, Jason A., Trachana, Maria, Jung, Lawrence K., Olson, Judyann, Minden, Kirsten, Quartier, Pierre, Bereswill, Mareike, Kalabic, Jasmina, Kupper, Hartmut, Lovell, Daniel J., Martini, Alberto, Ruperto, Nicolino
Publicado 2020